Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TLR8 agonist 2

😃Good
Catalog No. T40039Cas No. 2412937-64-3
Alias TLR8 agonist 2

TLR8 agonist 2 is a highly effective and specific compound that activates TLR8, possessing an EC 50 of 3 nM in human TLR8. Notably, TLR8 agonist 2 demonstrates lower activity towards human TLR7, with an EC 50 of 33.33 μM.

TLR8 agonist 2

TLR8 agonist 2

😃Good
Catalog No. T40039Alias TLR8 agonist 2Cas No. 2412937-64-3
TLR8 agonist 2 is a highly effective and specific compound that activates TLR8, possessing an EC 50 of 3 nM in human TLR8. Notably, TLR8 agonist 2 demonstrates lower activity towards human TLR7, with an EC 50 of 33.33 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$970InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
TLR8 agonist 2 is a highly effective and specific compound that activates TLR8, possessing an EC 50 of 3 nM in human TLR8. Notably, TLR8 agonist 2 demonstrates lower activity towards human TLR7, with an EC 50 of 33.33 μM.
Targets&IC50
TLR7:33.33 μM (EC50), TLR8:3 nM (EC50)
In vitro
TLR8 agonist 2 (Example 1) enhances the production of TNF-α, IL-12p40, IFN-γ, and IFN-α in human peripheral blood mononuclear cells (hPBMC), with EC50 values of 105 nM, 26 nM, 29 nM, and 2800 nM, respectively[1].
In vivo
Pharmacokinetic parameters for TLR8 agonist 2 (Example 1) in mice were determined following intravenous (i.v.) administration at 1 mg/kg and oral (p.o.) administration at 5 mg/kg. The half-life (T 1/2) of TLR8 agonist 2 was observed to be 0.25 hours (i.v.) and 0.5 hours (p.o.), with the area under the curve (AUC) last recorded at 450 ng/mL*hr (i.v.) and 624 ng/mL*hr (p.o.). The bioavailability (%F) after oral administration was found to be 27.7%[1].
SynonymsTLR8 agonist 2
Chemical Properties
Molecular Weight326.408
FormulaC16H22N8
Cas No.2412937-64-3
SmilesCCCC[C@](C)(Cc1nnc[nH]1)Nc1nc(N)nc2cnccc12
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy TLR8 agonist 2 | purchase TLR8 agonist 2 | TLR8 agonist 2 cost | order TLR8 agonist 2 | TLR8 agonist 2 chemical structure | TLR8 agonist 2 in vivo | TLR8 agonist 2 in vitro | TLR8 agonist 2 formula | TLR8 agonist 2 molecular weight